This study aimed to evaluate the association between AR expression and survival outcomes in a real-world Chinese cohort.<h4>Methods</h4>We retrospectively analyzed 422 patients with primary ER+/HER2- breast cancer treated at the First Affiliated Hospital of Chongqing Medical University between December 2020 and November 2021. Here, ERBB2 is linked to breast carcinoma.